Bronchopulmonary dysplasia (Q28237555)

bronchopulmonary dysplasia

Europe PubMed Central

title

Bronchopulmonary dysplasia (English)

0 references

main subject

1 reference

2

Anne Greenough

0 references

author name string

John P Kinsella

series ordinal

1

0 references

Steven H Abman

series ordinal

3

0 references

language of work or name

English

0 references

publication date

29 April 2006

0 references

published in

The Lancet

0 references

volume

367

0 references

issue

9520

0 references

page(s)

1421-31

0 references

cites work

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Bronchopulmonary dysplasia: Clinical presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Atypical chronic lung disease patterns in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

A simple chest radiograph score to predict chronic lung disease in prematurely born infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Frequent wheeze at follow up of very preterm infants: which factors are predictive?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Variability in the use of supplemental oxygen for bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Impact of a physiologic definition on bronchopulmonary dysplasia rates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Amniotic fluid tumor necrosis factor-α and the risk of respiratory distress syndrome among preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Antenatal factors and the development of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Effects of antenatal endotoxin and glucocorticoids on the lungs of preterm lambs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Preterm lung function after retreatment with antenatal betamethasone in preterm lambs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Preparation for birth into an O2-rich environment: the antioxidant enzymes in the developing rabbit lung

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Extracellular superoxide dismutase protects lung development in hyperoxia-exposed newborn mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Ventilator-induced lung injury: lessons from experimental studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Lung overexpansion increases pulmonary microvascular protein permeability in young lambs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Lung Surfactant and the Pathogenesis of Neonatal Bronchiolar Lesions Induced by Artificial Ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

The role of inflammation in the pathogenesis of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Inflammatory mediators and bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Markers and mediators of inflammation in neonatal lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Inositol for respiratory distress syndrome in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Growth factors in the fetal and neonatal lung

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Inhibition of angiogenesis decreases alveolarization in the developing rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Intra-amniotic endotoxin induces lung maturation by direct effects on the developing respiratory tract in preterm sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Polymorphisms of surfactant protein B encoding gene: modifiers of the course of neonatal respiratory distress syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Genetic influences and neonatal lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Mucosal tumor necrosis factor-alpha production and extensive disruption of sulfated glycosaminoglycans begin within hours of birth in neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Cysteinyl leukotriene involvement in chronic lung disease in premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Early prediction of chronic lung disease by pulmonary function testing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Expiratory flow limitation in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

The pulmonary circulation in bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Pulmonary hypertension in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Systemic hypertension in infants with severe bronchopulmonary dysplasia: associated clinical factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Pulmonary function until two years of life in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Serial determination of pulmonary function in infants with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Longitudinal follow-up of lung function from childhood to adolescence in prematurely born patients with neonatal chronic lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Late pulmonary sequelae of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Pulmonary function at follow-up of very preterm infants from the United Kingdom oscillation study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Airways resistance and lung volume before and after bronchodilator therapy in symptomatic preterm infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Influence of postnatally administered glucocorticoids on rat lung growth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Long-term pulmonary sequelae of severe bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Speech and language outcomes of children with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Severe bronchopulmonary dysplasia. Predictors of survival and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Growth and development in children recovering from bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Poor prognosis after prolonged ventilation for bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Prolonged ventilation and intact survival in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Synchronized mechanical ventilation for respiratory support in newborn infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Cumulative Metaanalysis of High-frequency Versus Conventional Ventilation in Premature Neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Randomised trial of fluid restriction in ventilated very low birthweight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Randomised controlled trial of postnatal sodium supplementation on oxygen dependency and body weight in 25-30 week gestational age infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Early origins of cardiovascular disease: is there a unifying hypothesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Clinical trials of postnatal corticosteroids: inhaled and systemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Postnatal corticosteroids for preterm infants--do what we say, not what we do.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Impact of Postnatal Systemic Corticosteroids on Mortality and Cerebral Palsy in Preterm Infants: Effect Modification by Risk for Chronic Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Inhaled steroids for neonatal chronic lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Clinical problem-solving: diagnosis of tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Fluticasone inhalation in moderate cases of bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021

Inhaled nitric oxide for premature infants with severe respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968615-7

7 January 2021